{
  "ticker": "LLY",
  "target_date": "2025-05-16",
  "actual_date": "2025-05-16",
  "collected_at": "2025-12-08T11:46:34.650439",
  "price": {
    "open": 737.3,
    "high": 756.1,
    "low": 735.3,
    "close": 754.6218872070312,
    "volume": 4645100,
    "change_1d_pct": 3.5,
    "change_7d_pct": -2.29,
    "change_30d_pct": -3.82
  },
  "technicals": {
    "rsi_14": 33.22,
    "sma_20": 798.78,
    "sma_50": 797.44,
    "macd": -20.19,
    "macd_signal": -12.542,
    "macd_histogram": -7.648,
    "bb_upper": 912.81,
    "bb_lower": 684.76,
    "price_vs_sma20_pct": -5.53,
    "price_vs_sma50_pct": -5.37,
    "volume_ratio": 0.94
  },
  "fundamentals": {
    "market_cap": 892082061312,
    "pe_ratio": 48.756493,
    "forward_pe": 43.915268,
    "price_to_book": 37.46687,
    "price_to_sales": 15.013212,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.51,
    "pct_from_52w_low": 59.53
  },
  "macro": {
    "spy": {
      "price": 590.81,
      "change_1d_pct": 0.63,
      "change_7d_pct": 5.16
    },
    "vix": {
      "level": 17.24,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.44
    },
    "dollar_index": {
      "level": 101.09
    },
    "gold": {
      "price": 3182.0
    },
    "regime": "BULL_LOW_VOL"
  },
  "news": [
    {
      "headline": "Analysis-Novo Nordisk should look to the US for its next CEO, analysts say",
      "source": "Yahoo",
      "datetime": 1747424978,
      "summary": "(Reuters) -As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look across the Atlantic for a leader deeply entrenched in the United States, by far its largest market, analysts told Reuters.  Novo, which manufactures the popular weight-loss drug Wegovy, s",
      "url": "https://finnhub.io/api/news?id=858a17d9a5f8021a7e35f74fb4df56b269a5d59d3a70662d788a98b907607c7d"
    },
    {
      "headline": "From insulin to Ozempic, history of Novo Nordisk's CEOs",
      "source": "Yahoo",
      "datetime": 1747419466,
      "summary": "Jorgensen, who joined in 2017, has had the shortest tenure of all.  Danish couple August and Marie Krogh founded Nordsik Insulinlaboratorium in 1923 and commercialized the production of insulin.  The company competed with Novo Terapeutisk Laboratorium, which was founded by brothers Harald and Thorva",
      "url": "https://finnhub.io/api/news?id=b545393dbf39812b39dfb33600214f2d7198e6d315d2d6e0aee568e0f15b5245"
    },
    {
      "headline": "Novo Nordisk's CEO Ousted: Deep-Value Opportunity With Sentiment Risks",
      "source": "SeekingAlpha",
      "datetime": 1747419307,
      "summary": "Novo Nordisk A/S' CEO transition sparks governance concerns, but internal succession ensures stability. Click for my updated look at NVO stock prospects.",
      "url": "https://finnhub.io/api/news?id=57e5aaf895c1427a927e0e97d7020fc8f5b0ea6eb2ff3d6043bc8456e27a76cc"
    },
    {
      "headline": "Eli Lilly strikes $1.3bn gene therapy deal with Rznomics",
      "source": "Yahoo",
      "datetime": 1747416168,
      "summary": "The deal gives Lilly access to the company\u2019s RNA-editing platform to develop therapies for sensorineural hearing loss.",
      "url": "https://finnhub.io/api/news?id=84fe7334351fe472ca78ed29eb06d15ab5cc11fc0ab4fe3369a1fb7a3b6ac36b"
    },
    {
      "headline": "Galaxy Digital on the Nasdaq, Novo ousts CEO, Virgin Galactic",
      "source": "Yahoo",
      "datetime": 1747415597,
      "summary": "Yahoo Finance host\u00a0Josh Lipton tracks today's top moving stocks and biggest market stories in this Market Minute, including Galaxy Digital's (GLXY) debut on the Nasdaq, Eli Lilly (LLY) getting a lift after Novo Nordisk (NVO) pushed out its CEO Lars Fruergaard J\u00f8rgensen, and Virgin Galactic (SPCE) fo",
      "url": "https://finnhub.io/api/news?id=0bd4f2b00fe34395a280493ea7c472364eff0f436c7c74b752320acb8b138420"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-05-15",
      "description": "xslF345X05/wk-form4_1747340244.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000144/xslF345X05/wk-form4_1747340244.xml"
    },
    {
      "form": "8-K",
      "date": "2025-05-08",
      "description": "lly-20250505.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000138/lly-20250505.htm"
    },
    {
      "form": "4",
      "date": "2025-05-05",
      "description": "xslF345X05/wk-form4_1746476222.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000134/xslF345X05/wk-form4_1746476222.xml"
    },
    {
      "form": "10-Q",
      "date": "2025-05-01",
      "description": "lly-20250331.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000132/lly-20250331.htm"
    },
    {
      "form": "8-K",
      "date": "2025-05-01",
      "description": "lly-20250501.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000129/lly-20250501.htm"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}